Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124126006 | 12412600 | 6 | F | 20160518 | 20160801 | 20160527 | 20160809 | EXP | US-UNITED THERAPEUTICS-UNT-2016-008223 | UNITED THERAPEUTICS | 16.75 | YR | M | Y | 120.00000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124126006 | 12412600 | 1 | PS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 0.007 ?G/KG, CONTINUING | 2100909 | 21272 | .007 | UG/KG | INJECTION | ||||||
| 124126006 | 12412600 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Intravenous drip | 12 MG, UNK | 21272 | 12 | MG | INJECTION | |||||||
| 124126006 | 12412600 | 3 | SS | REMODULIN | TREPROSTINIL | 1 | Unknown | 2.5 ML, UNK | 21272 | 2.5 | ML | INJECTION | |||||||
| 124126006 | 12412600 | 4 | SS | LETAIRIS | AMBRISENTAN | 1 | Oral | 5 MG, QD | 1412805A | 0 | 5 | MG | TABLET | QD | |||||
| 124126006 | 12412600 | 5 | SS | PROSTACYCLIN | EPOPROSTENOL | 1 | UNK | U | U | 0 | |||||||||
| 124126006 | 12412600 | 6 | C | ADCIRCA | TADALAFIL | 1 | 0 | ||||||||||||
| 124126006 | 12412600 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 124126006 | 12412600 | 8 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 0 | ||||||||||||
| 124126006 | 12412600 | 9 | C | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | 0 | ||||||||||||
| 124126006 | 12412600 | 10 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 124126006 | 12412600 | 11 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124126006 | 12412600 | 1 | Pulmonary arterial hypertension |
| 124126006 | 12412600 | 4 | Pulmonary arterial hypertension |
| 124126006 | 12412600 | 5 | Product used for unknown indication |
| 124126006 | 12412600 | 6 | Product used for unknown indication |
| 124126006 | 12412600 | 7 | Product used for unknown indication |
| 124126006 | 12412600 | 8 | Product used for unknown indication |
| 124126006 | 12412600 | 9 | Product used for unknown indication |
| 124126006 | 12412600 | 10 | Product used for unknown indication |
| 124126006 | 12412600 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124126006 | 12412600 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124126006 | 12412600 | Diarrhoea | |
| 124126006 | 12412600 | Enterovirus infection | |
| 124126006 | 12412600 | Headache | |
| 124126006 | 12412600 | Pain in jaw | |
| 124126006 | 12412600 | Pneumonia viral | |
| 124126006 | 12412600 | Rhinovirus infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124126006 | 12412600 | 1 | 20160509 | 0 | ||
| 124126006 | 12412600 | 2 | 20160511 | 0 | ||
| 124126006 | 12412600 | 3 | 20160512 | 0 | ||
| 124126006 | 12412600 | 4 | 20160118 | 0 | ||
| 124126006 | 12412600 | 5 | 20160509 | 0 |